(R)-Mirtazapine-13C-d3
Modify Date: 2024-01-02 22:24:24
(R)-Mirtazapine-13C-d3 structure
|
Common Name | (R)-Mirtazapine-13C-d3 | ||
|---|---|---|---|---|
| CAS Number | 61364-37-2 | Molecular Weight | 265.353 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 432.4±45.0 °C at 760 mmHg | |
| Molecular Formula | C17H19N3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 215.3±28.7 °C | |
Use of (R)-Mirtazapine-13C-d3(R)-Mirtazapine ((R)-Org3770) is a R(−)-enantiomer of Mirtazapine with antinociceptive properties in an animal model of acute thermal nociception. (R)-Mirtazapine is a 5-HT3 receptor antagonist. (R)-Mirtazapine is mainly metabolized by CYP3A4[1]. |
| Name | (R)-1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine |
|---|---|
| Synonym | More Synonyms |
| Description | (R)-Mirtazapine ((R)-Org3770) is a R(−)-enantiomer of Mirtazapine with antinociceptive properties in an animal model of acute thermal nociception. (R)-Mirtazapine is a 5-HT3 receptor antagonist. (R)-Mirtazapine is mainly metabolized by CYP3A4[1]. |
|---|---|
| Related Catalog | |
| Target |
5-HT3 receptor[1] |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 432.4±45.0 °C at 760 mmHg |
| Molecular Formula | C17H19N3 |
| Molecular Weight | 265.353 |
| Flash Point | 215.3±28.7 °C |
| Exact Mass | 265.157898 |
| PSA | 19.37000 |
| LogP | 2.75 |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.668 |
| (R)-1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine |
| (14bR)-2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine |
| (R)-1,2,3,4,10,14b-hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine |
| BIDD:GT0798 |
| Pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, (14bR)- |